Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinhard Marks

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Cellular Immunology|June 15, 2012
Rap1a deficiency modifies cytokine responses and MAPK-signaling in vitro and impairs the in vivo inflammatory responseAnnette Dorn, Anna Zoellner, Marie Follo, et al.
Frontiers in Medicine|March 12, 2021
Case Report: Refusal of an Veno-Arterial Extracorporeal Membrane Oxygenation Due to Malignant Disease? - An Extremely Rare Form of Cardiac Involvement in Acute Myeloid LeukemiaViviane Zotzmann, Tobias Wengenmayer, Corinna N Lang, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 26, 2018
Primary intraspinal non-Hodgkin's lymphoma: Case report and review of literatureLena-Alexandra Beume, Katharina Wolf, Horst Urbach, et al.
Annals of Hematology|April 2, 2021
Donor lymphocyte infusions after first allogeneic hematopoietic stem-cell transplantation in adults with acute myeloid leukemia: a single-center landmark analysisAndrés R Rettig, Gabriele Ihorst, Hartmut Bertz, et al.
Therapeutic Advances in Neurological Disorders|October 21, 2021
Vaccination in multiple sclerosis patients treated with highly effective disease-modifying drugs: an overview with consideration of cladribine tabletsRalf Gold, Gerd Fätkenheuer, Hans-Peter Hartung, et al.
Haematologica|September 22, 2018
Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of lifeChristine Greil, Monika Engelhardt, Gabriele Ihorst, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 3, 2018
Impact of Lung Function on Bronchiolitis Obliterans Syndrome and Outcome after Allogeneic Hematopoietic Cell Transplantation with Reduced-Intensity ConditioningJesús Duque-Afonso, Gabriele Ihorst, Miguel Waterhouse, et al.
Annals of Hematology|March 13, 2021
Treatment of therapy-related acute myeloid leukemia and underlying multiple myeloma with decitabine/venetoclax and daratumumabKhalid Shoumariyeh, Johannes Jung, Michael Rassner, et al.
Nuklearmedizin. Nuclear Medicine|April 9, 2024
FDG-PET/CT is a powerful tool to predict and evaluate response to chimeric antigen receptor (CAR) T-cell therapy in Non-Hodgkin-Lymphoma (NHL)Christoph-Ferdinand Wielenberg, Johannes Christian Fostitsch, Christian Volz, et al.
Pediatric Blood & Cancer|April 15, 2020
TIM-3 deficiency presenting with two clonally unrelated episodes of mesenteric and subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosisOliver Wegehaupt, Miriam Groß, Claudia Wehr, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Cellular Immunology|June 15, 2012
Rap1a deficiency modifies cytokine responses and MAPK-signaling in vitro and impairs the in vivo inflammatory responseAnnette Dorn, Anna Zoellner, Marie Follo, et al.
Frontiers in Medicine|March 12, 2021
Case Report: Refusal of an Veno-Arterial Extracorporeal Membrane Oxygenation Due to Malignant Disease? - An Extremely Rare Form of Cardiac Involvement in Acute Myeloid LeukemiaViviane Zotzmann, Tobias Wengenmayer, Corinna N Lang, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 26, 2018
Primary intraspinal non-Hodgkin's lymphoma: Case report and review of literatureLena-Alexandra Beume, Katharina Wolf, Horst Urbach, et al.
Annals of Hematology|April 2, 2021
Donor lymphocyte infusions after first allogeneic hematopoietic stem-cell transplantation in adults with acute myeloid leukemia: a single-center landmark analysisAndrés R Rettig, Gabriele Ihorst, Hartmut Bertz, et al.
Therapeutic Advances in Neurological Disorders|October 21, 2021
Vaccination in multiple sclerosis patients treated with highly effective disease-modifying drugs: an overview with consideration of cladribine tabletsRalf Gold, Gerd Fätkenheuer, Hans-Peter Hartung, et al.
Haematologica|September 22, 2018
Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of lifeChristine Greil, Monika Engelhardt, Gabriele Ihorst, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 3, 2018
Impact of Lung Function on Bronchiolitis Obliterans Syndrome and Outcome after Allogeneic Hematopoietic Cell Transplantation with Reduced-Intensity ConditioningJesús Duque-Afonso, Gabriele Ihorst, Miguel Waterhouse, et al.
Annals of Hematology|March 13, 2021
Treatment of therapy-related acute myeloid leukemia and underlying multiple myeloma with decitabine/venetoclax and daratumumabKhalid Shoumariyeh, Johannes Jung, Michael Rassner, et al.
Nuklearmedizin. Nuclear Medicine|April 9, 2024
FDG-PET/CT is a powerful tool to predict and evaluate response to chimeric antigen receptor (CAR) T-cell therapy in Non-Hodgkin-Lymphoma (NHL)Christoph-Ferdinand Wielenberg, Johannes Christian Fostitsch, Christian Volz, et al.
Pediatric Blood & Cancer|April 15, 2020
TIM-3 deficiency presenting with two clonally unrelated episodes of mesenteric and subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosisOliver Wegehaupt, Miriam Groß, Claudia Wehr, et al.
Pageof 8